FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Roche | Avastin | Clinical Trial Results

Avastin trial hit by heart failure cases

Tools

Roche (RHHBY) said enrollment into a late-stage U.S. trial of Avastin in breast cancer patients had been suspended after six patients suffered congestive heart failure. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Clinical Trial Results   Roche   Avastin